Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Noseguard for Prevention of Respiratory Infections in Real-World Use
Noseguard for Prevention of Respiratory Infections in Real-World Use

NCT07516977

Not Yet RecruitingNA

Sponsor: Daewoong Pharmaceutical Co. LTD.

Conditions: Respiratory Infection Virus, COVID-19, Influenza

Interventions: Noseguard and Noseguard Night

Countries: South Korea

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions. The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

Eligibility overview

Sex: ALL

Age: 19 Years to —

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* Adults aged ≥19 years
* Able to provide informed consent

Exclusion Criteria:

* Hypersensitivity to device components
* Current COVID-19 or influenza infection
* Severe nasal disease
* Pregnant or breastfeeding women
Locations (1)
  • Jeonju, South Korea